Apricus Wealth, LLC Acelrx Pharmaceuticals Inc Transaction History

Apricus Wealth, LLC

  • $151 Million
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022
BUY
$0.2 - $0.35 $1,000 - $1,750
5,000 Added 3.83%
135,500 $28,000
Q4 2021

Mar 09, 2022
BUY
$0.49 - $1.02 $63,945 - $133,110
130,500 New
130,500 $73,000

About ACELRX PHARMACEUTICALS INC

ACRX Quotes by TradingView
  • Ticker ACRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 7,366,600
  • Market Cap $8.32M
  • Description
  • AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...
More about ACRX
Track This Portfolio

Track Apricus Wealth, LLC Portfolio

Follow Apricus Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apricus Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apricus Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email